Fidelity International
LEGN icon

Fidelity International’s Legend Biotech LEGN Stock Holding History

Fidelity International’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
+8,307
New +$224K ﹤0.01% 994
2025
Q4 		– Sell
-41,777
Closed -$1.36M – 1050
2025
Q3 		$1.36M Buy
+41,777
New +$1.54M ﹤0.01% 763

Other funds holding LEGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $587M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Fidelity International's LEGN Position: Q2 2026 in Review

Fidelity International opened a new position in Legend Biotech (LEGN) in Q2 2026: 8,307 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #994 among its holdings. This is a return to the name: Fidelity International previously reported a position in LEGN as recently as Q3 2025.

Fidelity International first reported a position in LEGN in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.36M in Q3 2025. 156 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Fidelity International held 8,307 shares of Legend Biotech worth $240K as of Q2 2026.
  • Legend Biotech was a new Fidelity International position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #994 holding.
  • Fidelity International first reported a position in Legend Biotech in Q3 2025 and has held it in 2 quarters since.
  • Fidelity International's Legend Biotech position peaked at $1.36M in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.